MedPath

Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization

Not Applicable
Not yet recruiting
Conditions
ICH - Intracerebral Hemorrhage
TBI Traumatic Brain Injury
IVH- Intraventricular Hemorrhage
Registration Number
NCT07042048
Lead Sponsor
The Cooper Health System
Brief Summary

The goal of this clinical trial is to assess if EVD placement using augmented reality is non inferior to image-guidance systems for assistance in adult patients needing an EVD for spontaneous ICH with IVH or severe TBI. The main question it aims to answer is:

Can EVDs be placed successfully with at least equal safety and efficacy using augmented reality devices in comparison to using standard image-guidance techniques?

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • adult patient at time of screening
  • diagnosis of spontaneous ICH with IVH with severe TBI
  • Meet one or more of the following clinical or radiographic criteria:

Tissue swelling on imaging Dysmorphic ventricles on imaging Midline shift >2mm on imaging Mass effect on imaging Evans Index <0.3 on imaging Glasgow Coma Scale 3-8

  • admitted to Cooper University Health
  • requires an EVD
Exclusion Criteria
  • Other concomitant intracranial pathology (e.g., tumor, tumor-related edema/hemorrhage, congenital condition, etc.)
  • Concurrent participation in another research protocol for investigation of an experimental therapy
  • Known or suspected inability to adhere to study protocol or protocol requirements, as per the discretion of the investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Successful EVD catheter placementDuring procedure

Post-procedural non-contrast head CT will be reviewed by masked assessor to evaluate success of EVD placement per the Kakarla grading system. This grading system classifies catheter positioning into three grades based on postoperative imaging. Grade 1 indicates optimal placement in the ipsilateral frontal horn or third ventricle for effective drainage. Grade 2 represents functional but non-ideal placement in the contralateral ventricle or non-eloquent cortex. Grade 3 denotes suboptimal placement in eloquent cortex or non-target spaces, potentially leading to complications. Thus, a higher score means a worse outcome.

rate of complication during placementDuring procedure
Secondary Outcome Measures
NameTimeMethod
rate of catheter tip dispositionsDuring procedure
number of passes for placementDuring procedure
rate of AR or Stealth overlay failures on first tryDuring procedure
rate of EVD failurefrom placement to removal of EVD and assessed up to two weeks after
EVD dislodgment of occlusionfrom placement to removal of EVD and assessed up to two weeks after
rate of EVD replacement or revisionDuring procedure
rate of EVD associated hemorrhagefrom placement to removal of EVD and assessed up to two weeks after
rate if EVD-associated infectionfrom placement to removal of EVD and assessed up to two weeks after

Trial Locations

Locations (1)

Cooper University Health

🇺🇸

Camden, New Jersey, United States

Cooper University Health
🇺🇸Camden, New Jersey, United States
Corey Mossop, MD
Contact
856-342-2000
mossop-corey@cooperhealth.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.